Global Hyperimmune Globulins Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Page: 96

Published Date: 05 Jun 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Hyperimmune Globulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hyperimmune Globulins size is estimated to be XX million in 2021 from USD 1571.6 million in 2020, with a change of XX% between 2020 and 2021. The global Hyperimmune Globulins market size is expected to grow at a CAGR of 6.7% for the next five years.

Market segmentation
Hyperimmune Globulins market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Hepatitis B Immunoglobulins
    Rabies Immunoglobulins
    Tetanus Immunoglobulins
    Rho(D) Immunoglobulins
    Other

Market segment by Application can be divided into
    Government Institutions
    Private Sector
    Other

The key market players for global Hyperimmune Globulins market are listed below:
    CSL Behring
    Grifols
    Biotest
    Kedrion
    CBPO
    Emergent (Cangene)
    Kamada
    CNBG
    Hualan Bio
    Shanghai RAAS
    Sichuan Yuanda Shuyang
    ADMA Biologics

Market segment by Region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Hyperimmune Globulins product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyperimmune Globulins, with price, sales, revenue and global market share of Hyperimmune Globulins from 2019 to 2021.
Chapter 3, the Hyperimmune Globulins competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyperimmune Globulins breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hyperimmune Globulins market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Hyperimmune Globulins sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Hyperimmune Globulins Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Hyperimmune Globulins Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Hepatitis B Immunoglobulins
        1.2.3 Rabies Immunoglobulins
        1.2.4 Tetanus Immunoglobulins
        1.2.5 Rho(D) Immunoglobulins
        1.2.6 Other
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Hyperimmune Globulins Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Government Institutions
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Global Hyperimmune Globulins Market Size & Forecast
        1.4.1 Global Hyperimmune Globulins Sales in Value (2016-2026))
        1.4.2 Global Hyperimmune Globulins Sales in Volume (2016-2026)
        1.4.3 Global Hyperimmune Globulins Price by Type (2016-2026) & (USD/Unit)
    1.5 Global Hyperimmune Globulins Production Capacity Analysis
        1.5.1 Global Hyperimmune Globulins Total Production Capacity (2016-2026)
        1.5.2 Global Hyperimmune Globulins Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Hyperimmune Globulins Market Drivers
        1.6.2 Hyperimmune Globulins Market Restraints
        1.6.3 Hyperimmune Globulins Trends Analysis

2 Manufacturers Profiles
    2.1 CSL Behring
        2.1.1 CSL Behring Details
        2.1.2 CSL Behring Major Business
        2.1.3 CSL Behring Hyperimmune Globulins Product and Services
        2.1.4 CSL Behring Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Grifols
        2.2.1 Grifols Details
        2.2.2 Grifols Major Business
        2.2.3 Grifols Hyperimmune Globulins Product and Services
        2.2.4 Grifols Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Biotest
        2.3.1 Biotest Details
        2.3.2 Biotest Major Business
        2.3.3 Biotest Hyperimmune Globulins Product and Services
        2.3.4 Biotest Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Kedrion
        2.4.1 Kedrion Details
        2.4.2 Kedrion Major Business
        2.4.3 Kedrion Hyperimmune Globulins Product and Services
        2.4.4 Kedrion Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 CBPO
        2.5.1 CBPO Details
        2.5.2 CBPO Major Business
        2.5.3 CBPO Hyperimmune Globulins Product and Services
        2.5.4 CBPO Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Emergent (Cangene)
        2.6.1 Emergent (Cangene) Details
        2.6.2 Emergent (Cangene) Major Business
        2.6.3 Emergent (Cangene) Hyperimmune Globulins Product and Services
        2.6.4 Emergent (Cangene) Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Kamada
        2.7.1 Kamada Details
        2.7.2 Kamada Major Business
        2.7.3 Kamada Hyperimmune Globulins Product and Services
        2.7.4 Kamada Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 CNBG
        2.8.1 CNBG Details
        2.8.2 CNBG Major Business
        2.8.3 CNBG Hyperimmune Globulins Product and Services
        2.8.4 CNBG Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Hualan Bio
        2.9.1 Hualan Bio Details
        2.9.2 Hualan Bio Major Business
        2.9.3 Hualan Bio Hyperimmune Globulins Product and Services
        2.9.4 Hualan Bio Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Shanghai RAAS
        2.10.1 Shanghai RAAS Details
        2.10.2 Shanghai RAAS Major Business
        2.10.3 Shanghai RAAS Hyperimmune Globulins Product and Services
        2.10.4 Shanghai RAAS Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Sichuan Yuanda Shuyang
        2.11.1 Sichuan Yuanda Shuyang Details
        2.11.2 Sichuan Yuanda Shuyang Major Business
        2.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulins Product and Services
        2.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 ADMA Biologics
        2.12.1 ADMA Biologics Details
        2.12.2 ADMA Biologics Major Business
        2.12.3 ADMA Biologics Hyperimmune Globulins Product and Services
        2.12.4 ADMA Biologics Hyperimmune Globulins Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Hyperimmune Globulins Sales by Manufacturer
    3.1 Global Hyperimmune Globulins Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Hyperimmune Globulins Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Hyperimmune Globulins
    3.4 Market Concentration Rate
        3.4.1 Top 3 Hyperimmune Globulins Manufacturer Market Share
        3.4.2 Top 6 Hyperimmune Globulins Manufacturer Market Share
    3.5 Global Hyperimmune Globulins Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Hyperimmune Globulins Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions

4 Market Analysis by Region
    4.1 Global Hyperimmune Globulins Market Size by Region
        4.1.1 Global Hyperimmune Globulins Sales in Volume by Region (2016-2026)
        4.1.2 Global Hyperimmune Globulins Revenue by Region (2016-2026)
    4.2 North America Hyperimmune Globulins Revenue (2016-2026)
    4.3 Europe Hyperimmune Globulins Revenue (2016-2026)
    4.4 Asia-Pacific Hyperimmune Globulins Revenue (2016-2026)
    4.5 South America Hyperimmune Globulins Revenue (2016-2026)
    4.6 Middle East and Africa Hyperimmune Globulins Revenue (2016-2026)

5 Market Segment by Type
    5.1 Global Hyperimmune Globulins Sales in Volume by Type (2016-2026)
    5.2 Global Hyperimmune Globulins Revenue by Type (2016-2026)
    5.3 Global Hyperimmune Globulins Price by Type (2016-2026)

6 Market Segment by Application
    6.1 Global Hyperimmune Globulins Sales in Volume by Application (2016-2026)
    6.2 Global Hyperimmune Globulins Revenue by Application (2016-2026)
    6.3 Global Hyperimmune Globulins Price by Application (2016-2026)

7 North America by Country, by Type, and by Application
    7.1 North America Hyperimmune Globulins Sales by Type (2016-2026)
    7.2 North America Hyperimmune Globulins Sales by Application (2016-2026)
    7.3 North America Hyperimmune Globulins Market Size by Country
        7.3.1 North America Hyperimmune Globulins Sales in Volume by Country (2016-2026)
        7.3.2 North America Hyperimmune Globulins Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application
    8.1 Europe Hyperimmune Globulins Sales by Type (2016-2026)
    8.2 Europe Hyperimmune Globulins Sales by Application (2016-2026)
    8.3 Europe Hyperimmune Globulins Market Size by Country
        8.3.1 Europe Hyperimmune Globulins Sales in Volume by Country (2016-2026)
        8.3.2 Europe Hyperimmune Globulins Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Hyperimmune Globulins Sales by Type (2016-2026)
    9.2 Asia-Pacific Hyperimmune Globulins Sales by Application (2016-2026)
    9.3 Asia-Pacific Hyperimmune Globulins Market Size by Region
        9.3.1 Asia-Pacific Hyperimmune Globulins Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Hyperimmune Globulins Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application
    10.1 South America Hyperimmune Globulins Sales by Type (2016-2026)
    10.2 South America Hyperimmune Globulins Sales by Application (2016-2026)
    10.3 South America Hyperimmune Globulins Market Size by Country
        10.3.1 South America Hyperimmune Globulins Sales in Volume by Country (2016-2026)
        10.3.2 South America Hyperimmune Globulins Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Hyperimmune Globulins Sales by Type (2016-2026)
    11.2 Middle East & Africa Hyperimmune Globulins Sales by Application (2016-2026)
    11.3 Middle East & Africa Hyperimmune Globulins Market Size by Country
        11.3.1 Middle East & Africa Hyperimmune Globulins Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Hyperimmune Globulins Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Hyperimmune Globulins Typical Distributors
    12.3 Hyperimmune Globulins Typical Customers

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hyperimmune Globulins Revenue by Type, (USD Million), 2021-2026
    Table 2. Global Hyperimmune Globulins Revenue by Application, (USD Million), 2021-2026
    Table 3. CSL Behring Basic Information, Manufacturing Base and Competitors
    Table 4. CSL Behring Major Business
    Table 5. CSL Behring Hyperimmune Globulins Product and Services
    Table 6. CSL Behring Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 7. Grifols Basic Information, Manufacturing Base and Competitors
    Table 8. Grifols Major Business
    Table 9. Grifols Hyperimmune Globulins Product and Services
    Table 10. Grifols Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 11. Biotest Basic Information, Manufacturing Base and Competitors
    Table 12. Biotest Major Business
    Table 13. Biotest Hyperimmune Globulins Product and Services
    Table 14. Biotest Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 15. Kedrion Basic Information, Manufacturing Base and Competitors
    Table 16. Kedrion Major Business
    Table 17. Kedrion Hyperimmune Globulins Product and Services
    Table 18. Kedrion Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 19. CBPO Basic Information, Manufacturing Base and Competitors
    Table 20. CBPO Major Business
    Table 21. CBPO Hyperimmune Globulins Product and Services
    Table 22. CBPO Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 23. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
    Table 24. Emergent (Cangene) Major Business
    Table 25. Emergent (Cangene) Hyperimmune Globulins Product and Services
    Table 26. Emergent (Cangene) Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 27. Kamada Basic Information, Manufacturing Base and Competitors
    Table 28. Kamada Major Business
    Table 29. Kamada Hyperimmune Globulins Product and Services
    Table 30. Kamada Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 31. CNBG Basic Information, Manufacturing Base and Competitors
    Table 32. CNBG Major Business
    Table 33. CNBG Hyperimmune Globulins Product and Services
    Table 34. CNBG Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 35. Hualan Bio Basic Information, Manufacturing Base and Competitors
    Table 36. Hualan Bio Major Business
    Table 37. Hualan Bio Hyperimmune Globulins Product and Services
    Table 38. Hualan Bio Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 39. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
    Table 40. Shanghai RAAS Major Business
    Table 41. Shanghai RAAS Hyperimmune Globulins Product and Services
    Table 42. Shanghai RAAS Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 43. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
    Table 44. Sichuan Yuanda Shuyang Major Business
    Table 45. Sichuan Yuanda Shuyang Hyperimmune Globulins Product and Services
    Table 46. Sichuan Yuanda Shuyang Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 47. ADMA Biologics Basic Information, Manufacturing Base and Competitors
    Table 48. ADMA Biologics Major Business
    Table 49. ADMA Biologics Hyperimmune Globulins Product and Services
    Table 50. ADMA Biologics Hyperimmune Globulins Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
    Table 51. Global Hyperimmune Globulins Sales by Manufacturer (2019-2021e) & (K Units)
    Table 52. Global Hyperimmune Globulins Revenue by Manufacturer (2019-2021e) & (USD Million)
    Table 53. Market Position of Manufacturers in Hyperimmune Globulins, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
    Table 54. Global Hyperimmune Globulins Production Capacity by Company, (K Units): 2020 VS 2021
    Table 55. Head Office and Hyperimmune Globulins Production Site of Key Manufacturer
    Table 56. Hyperimmune Globulins New Entrant and Capacity Expansion Plans
    Table 57. Hyperimmune Globulins Mergers & Acquisitions in the Past Five Years
    Table 58. Global Hyperimmune Globulins Sales by Region (2016-2021e) & (K Units)
    Table 59. Global Hyperimmune Globulins Sales by Region (2021-2026) & (K Units)
    Table 60. Global Hyperimmune Globulins Revenue by Region (2016-2021e) & (USD Million)
    Table 61. Global Hyperimmune Globulins Revenue by Region (2021-2026) & (USD Million)
    Table 62. Global Hyperimmune Globulins Sales by Type (2016-2021e) & (K Units)
    Table 63. Global Hyperimmune Globulins Sales by Type (2021-2026) & (K Units)
    Table 64. Global Hyperimmune Globulins Revenue by Type (2016-2021e) & (USD Million)
    Table 65. Global Hyperimmune Globulins Revenue by Type (2021-2026) & (USD Million)
    Table 66. Global Hyperimmune Globulins Price by Type (2016-2021e) & (USD/Unit)
    Table 67. Global Hyperimmune Globulins Price by Type (2021-2026) & (USD/Unit)
    Table 68. Global Hyperimmune Globulins Sales by Application (2016-2021e) & (K Units)
    Table 69. Global Hyperimmune Globulins Sales by Application (2021-2026) & (K Units)
    Table 70. Global Hyperimmune Globulins Revenue by Application (2016-2021e) & (USD Million)
    Table 71. Global Hyperimmune Globulins Revenue by Application (2021-2026) & (USD Million)
    Table 72. Global Hyperimmune Globulins Price by Application (2016-2021e) & (USD/Unit)
    Table 73. Global Hyperimmune Globulins Price by Application (2021-2026) & (USD/Unit)
    Table 74. North America Hyperimmune Globulins Sales by Country (2016-2021e) & (K Units)
    Table 75. North America Hyperimmune Globulins Sales by Country (2021-2026) & (K Units)
    Table 76. North America Hyperimmune Globulins Revenue by Country (2016-2021e) & (USD Million)
    Table 77. North America Hyperimmune Globulins Revenue by Country (2021-2026) & (USD Million)
    Table 78. North America Hyperimmune Globulins Sales by Type (2016-2021e) & (K Units)
    Table 79. North America Hyperimmune Globulins Sales by Type (2021-2026) & (K Units)
    Table 80. North America Hyperimmune Globulins Sales by Application (2016-2021e) & (K Units)
    Table 81. North America Hyperimmune Globulins Sales by Application (2021-2026) & (K Units)
    Table 82. Europe Hyperimmune Globulins Sales by Country (2016-2021e) & (K Units)
    Table 83. Europe Hyperimmune Globulins Sales by Country (2021-2026) & (K Units)
    Table 84. Europe Hyperimmune Globulins Revenue by Country (2016-2021e) & (USD Million)
    Table 85. Europe Hyperimmune Globulins Revenue by Country (2021-2026) & (USD Million)
    Table 86. Europe Hyperimmune Globulins Sales by Type (2016-2021e) & (K Units)
    Table 87. Europe Hyperimmune Globulins Sales by Type (2021-2026) & (K Units)
    Table 88. Europe Hyperimmune Globulins Sales by Application (2016-2021e) & (K Units)
    Table 89. Europe Hyperimmune Globulins Sales by Application (2021-2026) & (K Units)
    Table 90. Asia-Pacific Hyperimmune Globulins Sales by Region (2016-2021e) & (K Units)
    Table 91. Asia-Pacific Hyperimmune Globulins Sales by Region (2021-2026) & (K Units)
    Table 92. Asia-Pacific Hyperimmune Globulins Revenue by Region (2016-2021e) & (USD Million)
    Table 93. Asia-Pacific Hyperimmune Globulins Revenue by Region (2021-2026) & (USD Million)
    Table 94. Asia-Pacific Hyperimmune Globulins Sales by Type (2016-2021e) & (K Units)
    Table 95. Asia-Pacific Hyperimmune Globulins Sales by Type (2021-2026) & (K Units)
    Table 96. Asia-Pacific Hyperimmune Globulins Sales by Application (2016-2021e) & (K Units)
    Table 97. Asia-Pacific Hyperimmune Globulins Sales by Application (2021-2026) & (K Units)
    Table 98. South America Hyperimmune Globulins Sales by Country (2016-2021e) & (K Units)
    Table 99. South America Hyperimmune Globulins Sales by Country (2021-2026) & (K Units)
    Table 100. South America Hyperimmune Globulins Revenue by Country (2016-2021e) & (USD Million)
    Table 101. South America Hyperimmune Globulins Revenue by Country (2021-2026) & (USD Million)
    Table 102. South America Hyperimmune Globulins Sales by Type (2016-2021e) & (K Units)
    Table 103. South America Hyperimmune Globulins Sales by Type (2021-2026) & (K Units)
    Table 104. South America Hyperimmune Globulins Sales by Application (2016-2021e) & (K Units)
    Table 105. South America Hyperimmune Globulins Sales by Application (2021-2026) & (K Units)
    Table 106. Middle East & Africa Hyperimmune Globulins Sales by Country (2016-2021e) & (K Units)
    Table 107. Middle East & Africa Hyperimmune Globulins Sales by Country (2021-2026) & (K Units)
    Table 108. Middle East & Africa Hyperimmune Globulins Revenue by Country (2016-2021e) & (USD Million)
    Table 109. Middle East & Africa Hyperimmune Globulins Revenue by Country (2021-2026) & (USD Million)
    Table 110. Middle East & Africa Hyperimmune Globulins Sales by Type (2016-2021e) & (K Units)
    Table 111. Middle East & Africa Hyperimmune Globulins Sales by Type (2021-2026) & (K Units)
    Table 112. Middle East & Africa Hyperimmune Globulins Sales by Application (2016-2021e) & (K Units)
    Table 113. Middle East & Africa Hyperimmune Globulins Sales by Application (2021-2026) & (K Units)
    Table 114. Direct Channel Pros & Cons
    Table 115. Indirect Channel Pros & Cons
    Table 116. Hyperimmune Globulins Typical Distributors
    Table 117. Hyperimmune Globulins Typical Customers
List of Figures
    Figure 1. Hyperimmune Globulins Picture
    Figure 2. Global Hyperimmune Globulins Sales Market Share by Type in 2020
    Figure 3. Hepatitis B Immunoglobulins
    Figure 4. Rabies Immunoglobulins
    Figure 5. Tetanus Immunoglobulins
    Figure 6. Rho(D) Immunoglobulins
    Figure 7. Other
    Figure 8. Global Hyperimmune Globulins Sales Market Share by Application in 2020
    Figure 9. Government Institutions
    Figure 10. Private Sector
    Figure 11. Other
    Figure 12. Global Hyperimmune Globulins Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
    Figure 13. Global Hyperimmune Globulins Market Size and Forecast (2016-2026) & (USD Million)
    Figure 14. Global Hyperimmune Globulins Sales (2016-2026) & (K Units)
    Figure 15. Global Hyperimmune Globulins Price by Type (2016-2026) & (USD/Unit)
    Figure 16. Global Hyperimmune Globulins Production Capacity (2016-2026) & (K Units)
    Figure 17. Global Hyperimmune Globulins Production Capacity by Geographic Region: 2020 VS 2021
    Figure 18. Hyperimmune Globulins Market Drivers
    Figure 19. Hyperimmune Globulins Market Restraints
    Figure 20. Hyperimmune Globulins Market Trends
    Figure 21. Global Hyperimmune Globulins Sales Market Share by Manufacturer in 2020
    Figure 22. Global Hyperimmune Globulins Revenue Market Share by Manufacturer in 2020
    Figure 23. Hyperimmune Globulins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    Figure 24. Top 3 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2020
    Figure 25. Top 6 Hyperimmune Globulins Manufacturer (Revenue) Market Share in 2020
    Figure 26. Global Hyperimmune Globulins Sales Market Share by Region (2016-2026)
    Figure 27. Global Hyperimmune Globulins Revenue Market Share by Region (2016-2026)
    Figure 28. North America Hyperimmune Globulins Revenue (2016-2026) & (USD Million)
    Figure 29. Europe Hyperimmune Globulins Revenue (2016-2026) & (USD Million)
    Figure 30. Asia-Pacific Hyperimmune Globulins Revenue (2016-2026) & (USD Million)
    Figure 31. South America Hyperimmune Globulins Revenue (2016-2026) & (USD Million)
    Figure 32. Middle East & Africa Hyperimmune Globulins Revenue (2016-2026) & (USD Million)
    Figure 33. Global Hyperimmune Globulins Sales Market Share by Type (2016-2026)
    Figure 34. Global Hyperimmune Globulins Revenue Market Share by Type (2016-2026)
    Figure 35. Global Hyperimmune Globulins Price by Type (2016-2026) & (USD/Unit)
    Figure 36. Global Hyperimmune Globulins Sales Market Share by Application (2016-2026)
    Figure 37. Global Hyperimmune Globulins Revenue Market Share by Application (2016-2026)
    Figure 38. Global Hyperimmune Globulins Price by Application (2016-2026) & (USD/Unit)
    Figure 39. North America Hyperimmune Globulins Sales Market Share by Type (2016-2026)
    Figure 40. North America Hyperimmune Globulins Sales Market Share by Application (2016-2026)
    Figure 41. North America Hyperimmune Globulins Sales Market Share by Country (2016-2026)
    Figure 42. North America Hyperimmune Globulins Revenue Market Share by Country (2016-2026)
    Figure 43. United States Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Canada Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 45. Mexico Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 46. Europe Hyperimmune Globulins Sales Market Share by Type (2016-2026)
    Figure 47. Europe Hyperimmune Globulins Sales Market Share by Application (2016-2026)
    Figure 48. Europe Hyperimmune Globulins Sales Market Share by Country (2016-2026)
    Figure 49. Europe Hyperimmune Globulins Revenue Market Share by Country (2016-2026)
    Figure 50. Germany Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. France Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. United Kingdom Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 53. Russia Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 54. Italy Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 55. Asia-Pacific Hyperimmune Globulins Sales Market Share by Region (2016-2026)
    Figure 56. Asia-Pacific Hyperimmune Globulins Sales Market Share by Application (2016-2026)
    Figure 57. Asia-Pacific Hyperimmune Globulins Sales Market Share by Region (2016-2026)
    Figure 58. Asia-Pacific Hyperimmune Globulins Revenue Market Share by Region (2016-2026)
    Figure 59. China Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Japan Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. Korea Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 62. India Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 63. Southeast Asia Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Australia Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South America Hyperimmune Globulins Sales Market Share by Type (2016-2026)
    Figure 66. South America Hyperimmune Globulins Sales Market Share by Application (2016-2026)
    Figure 67. South America Hyperimmune Globulins Sales Market Share by Country (2016-2026)
    Figure 68. South America Hyperimmune Globulins Revenue Market Share by Country (2016-2026)
    Figure 69. Brazil Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Argentina Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. Middle East & Africa Hyperimmune Globulins Sales Market Share by Type (2016-2026)
    Figure 72. Middle East & Africa Hyperimmune Globulins Sales Market Share by Application (2016-2026)
    Figure 73. Middle East & Africa Hyperimmune Globulins Sales Market Share by Country (2016-2026)
    Figure 74. Middle East & Africa Hyperimmune Globulins Revenue Market Share by Country (2016-2026)
    Figure 75. Turkey Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 76. Egypt Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 77. Saudi Arabia Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. South Africa Hyperimmune Globulins Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. Sales Channel: Direct Channel vs Indirect Channel
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

CSL Behring
Grifols
Biotest
Kedrion
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai RAAS
Sichuan Yuanda Shuyang
ADMA Biologics

Related Reports

Global Hyperimmune Globulins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Global Hyperimmune Globulins Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

The Hyperimmune Globulins market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global Hyperimmune Globulins Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Hyperimmune Globulins Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.

Global Hyperimmune Globulins Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Hyperimmune Globulins Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Hyperimmune Globulins market size was valued at USD 1742 million in 2023 and is forecast to a readjusted size of USD 2742.7 million by 2030 with a CAGR of 6.7% during review period.

Global Hyperimmune Globulins Supply, Demand and Key Producers, 2024-2030

Global Hyperimmune Globulins Supply, Demand and Key Producers, 2024-2030

date 10 Feb 2024

date Pharma & Healthcare

The global Hyperimmune Globulins market size is expected to reach $ 2742.7 million by 2030, rising at a market growth of 6.7% CAGR during the forecast period (2024-2030).

Product Tags

hyperimmune globulins

human hyperimmune globulins

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>